Our Capabilities
Three integrated divisions — anchored by the Portfolio Stewardship Division — that together form a comprehensive, institutional-grade pharmaceutical operating platform for African healthcare.
Ansilo's integrated pharmaceutical asset stewardship platform gives multinational companies a trusted South African partner for strategic legacy transfers, commercial partnerships, and specialist portfolio services — backed by institutional-grade regulatory, pharmacovigilance, quality, and supply chain capability.
Portfolio Stewardship Division
Integrated pharmaceutical capability
Local manufacturing capability development, contract manufacturing partnerships, and generic medicines development designed to strengthen African supply chain resilience.
Pharmaceutical Manufacturing
Integrated pharmaceutical capability
Comprehensive pharmaceutical quality testing, stability services, GMP-compliant operations, and regulatory dossier management ensuring product integrity and patient safety.
Quality Systems & Regulatory Compliance
Integrated pharmaceutical capability
We welcome partnership inquiries from pharmaceutical companies, contract manufacturing partners, and healthcare organisations.
Contact Our Portfolio Stewardship Team